Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.

INTRODUCTION: A novel A/H1N1 virus is the cause of the present influenza pandemic; vaccination is a key countermeasure, however, few data assessing prior seasonal vaccine effectiveness (VE) against the pandemic strain of H1N1 (pH1N1) virus are available. MATERIALS AND METHODS: Surveillance of influe...

Full description

Bibliographic Details
Main Authors: Matthew C Johns, Angelia A Eick, David L Blazes, Seung-eun Lee, Christopher L Perdue, Robert Lipnick, Kelly G Vest, Kevin L Russell, Robert F DeFraites, Jose L Sanchez
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2873284?pdf=render
_version_ 1818017528359682048
author Matthew C Johns
Angelia A Eick
David L Blazes
Seung-eun Lee
Christopher L Perdue
Robert Lipnick
Kelly G Vest
Kevin L Russell
Robert F DeFraites
Jose L Sanchez
author_facet Matthew C Johns
Angelia A Eick
David L Blazes
Seung-eun Lee
Christopher L Perdue
Robert Lipnick
Kelly G Vest
Kevin L Russell
Robert F DeFraites
Jose L Sanchez
author_sort Matthew C Johns
collection DOAJ
description INTRODUCTION: A novel A/H1N1 virus is the cause of the present influenza pandemic; vaccination is a key countermeasure, however, few data assessing prior seasonal vaccine effectiveness (VE) against the pandemic strain of H1N1 (pH1N1) virus are available. MATERIALS AND METHODS: Surveillance of influenza-related medical encounter data of active duty military service members stationed in the United States during the period of April-October 2009 with comparison of pH1N1-confirmed cases and location and date-matched controls. Crude odds ratios (OR) and VE estimates for immunized versus non-immunized were calculated as well as adjusted OR (AOR) controlling for sex, age group, and history of prior influenza vaccination. Separate stratified VE analyses by vaccine type (trivalent inactivated [TIV] or live attenuated [LAIV]), age groups and hospitalization status were also performed. For the period of April 20 to October 15, 2009, a total of 1,205 cases of pH1N1-confirmed cases were reported, 966 (80%) among males and over one-half (58%) under 25 years of age. Overall VE for service members was found to be 45% (95% CI, 33 to 55%). Immunization with prior season's TIV (VE = 44%, 95% CI, 32 to 54%) as well as LAIV (VE = 24%, 95% CI, 6 to 38%) were both found to be associated with protection. Of significance, VE against a severe disease outcome was higher (VE = 62%, 95% CI, 14 to 84%) than against milder outcomes (VE = 42%, 95% CI, 29 to 53%). CONCLUSION: A moderate association with protection against clinically apparent, laboratory-confirmed Pandemic (H1N1) 2009-associated illness was found for immunization with either TIV or LAIV 2008-09 seasonal influenza vaccines. This association with protection was found to be especially apparent for severe disease as compared to milder outcome, as well as in the youngest and older populations. Prior vaccination with seasonal influenza vaccines in 2004-08 was also independently associated with protection.
first_indexed 2024-04-14T07:28:09Z
format Article
id doaj.art-5565e216dbe94bc093ecc830e0d30536
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T07:28:09Z
publishDate 2010-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5565e216dbe94bc093ecc830e0d305362022-12-22T02:05:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-01-0155e1072210.1371/journal.pone.0010722Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.Matthew C JohnsAngelia A EickDavid L BlazesSeung-eun LeeChristopher L PerdueRobert LipnickKelly G VestKevin L RussellRobert F DeFraitesJose L SanchezINTRODUCTION: A novel A/H1N1 virus is the cause of the present influenza pandemic; vaccination is a key countermeasure, however, few data assessing prior seasonal vaccine effectiveness (VE) against the pandemic strain of H1N1 (pH1N1) virus are available. MATERIALS AND METHODS: Surveillance of influenza-related medical encounter data of active duty military service members stationed in the United States during the period of April-October 2009 with comparison of pH1N1-confirmed cases and location and date-matched controls. Crude odds ratios (OR) and VE estimates for immunized versus non-immunized were calculated as well as adjusted OR (AOR) controlling for sex, age group, and history of prior influenza vaccination. Separate stratified VE analyses by vaccine type (trivalent inactivated [TIV] or live attenuated [LAIV]), age groups and hospitalization status were also performed. For the period of April 20 to October 15, 2009, a total of 1,205 cases of pH1N1-confirmed cases were reported, 966 (80%) among males and over one-half (58%) under 25 years of age. Overall VE for service members was found to be 45% (95% CI, 33 to 55%). Immunization with prior season's TIV (VE = 44%, 95% CI, 32 to 54%) as well as LAIV (VE = 24%, 95% CI, 6 to 38%) were both found to be associated with protection. Of significance, VE against a severe disease outcome was higher (VE = 62%, 95% CI, 14 to 84%) than against milder outcomes (VE = 42%, 95% CI, 29 to 53%). CONCLUSION: A moderate association with protection against clinically apparent, laboratory-confirmed Pandemic (H1N1) 2009-associated illness was found for immunization with either TIV or LAIV 2008-09 seasonal influenza vaccines. This association with protection was found to be especially apparent for severe disease as compared to milder outcome, as well as in the youngest and older populations. Prior vaccination with seasonal influenza vaccines in 2004-08 was also independently associated with protection.http://europepmc.org/articles/PMC2873284?pdf=render
spellingShingle Matthew C Johns
Angelia A Eick
David L Blazes
Seung-eun Lee
Christopher L Perdue
Robert Lipnick
Kelly G Vest
Kevin L Russell
Robert F DeFraites
Jose L Sanchez
Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
PLoS ONE
title Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
title_full Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
title_fullStr Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
title_full_unstemmed Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
title_short Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
title_sort seasonal influenza vaccine and protection against pandemic h1n1 2009 associated illness among us military personnel
url http://europepmc.org/articles/PMC2873284?pdf=render
work_keys_str_mv AT matthewcjohns seasonalinfluenzavaccineandprotectionagainstpandemich1n12009associatedillnessamongusmilitarypersonnel
AT angeliaaeick seasonalinfluenzavaccineandprotectionagainstpandemich1n12009associatedillnessamongusmilitarypersonnel
AT davidlblazes seasonalinfluenzavaccineandprotectionagainstpandemich1n12009associatedillnessamongusmilitarypersonnel
AT seungeunlee seasonalinfluenzavaccineandprotectionagainstpandemich1n12009associatedillnessamongusmilitarypersonnel
AT christopherlperdue seasonalinfluenzavaccineandprotectionagainstpandemich1n12009associatedillnessamongusmilitarypersonnel
AT robertlipnick seasonalinfluenzavaccineandprotectionagainstpandemich1n12009associatedillnessamongusmilitarypersonnel
AT kellygvest seasonalinfluenzavaccineandprotectionagainstpandemich1n12009associatedillnessamongusmilitarypersonnel
AT kevinlrussell seasonalinfluenzavaccineandprotectionagainstpandemich1n12009associatedillnessamongusmilitarypersonnel
AT robertfdefraites seasonalinfluenzavaccineandprotectionagainstpandemich1n12009associatedillnessamongusmilitarypersonnel
AT joselsanchez seasonalinfluenzavaccineandprotectionagainstpandemich1n12009associatedillnessamongusmilitarypersonnel